Doctor hunts for top-quality stool donors in Boston

Elizabeth Hohmann, an infectious disease specialist at Massachusetts General Hospital, spends her days screening potential stool donors for faecal transplants that treat stubborn gut infections. With only about one percent of respondents qualifying, the process is challenging but rewarding. Her work has restored health to patients who previously couldn't function normally.

For 15 years, Elizabeth Hohmann has led the faecal transplant program at Massachusetts General Hospital in Boston, transforming donated stools into oral capsules to combat recurrent Clostridioides difficile infections. These infections, which cause severe diarrhoea and resist antibiotics, affect many patients, but the transplants introduce beneficial gut bacteria to outcompete the harmful ones.

Finding suitable donors is no easy task. Hohmann advertises online, offering $1,200 for a month's donations, yet only around one percent pass the rigorous checks. Candidates must avoid being healthcare workers or recent travellers to South-East Asia due to risks of drug-resistant bacteria, and they need to be lean to prevent obesity transmission. Successful applicants undergo blood tests for infections like HIV and covid-19, plus a rectal exam for gut issues.

Ideal donors are often fitness buffs with diets heavy on fruits, vegetables, and whole grains, shunning ultra-processed foods. Hohmann notes that while some centres prefer vegans, her top donors have been omnivores. Donations occur over two to four weeks, with donors visiting the hospital daily for bowel movements, often prompted by coffee. The fresh stool is blended with saline, filtered, and encapsulated promptly.

Post-donation re-screening ensures no new infections, like Salmonella, have arisen. The impact is profound: one patient, previously too ill to work, now manages 30 hours weekly. 'I keep doing it because it really does make a huge difference in some people’s lives,' Hohmann says. As retirement nears, she struggles to find a successor, with colleagues recoiling at the hands-on nature of the job.

Verwandte Artikel

Illustration of glowing engineered bacterial pills detecting gut bleeding in a mouse intestine model.
Bild generiert von KI

Engineered bacterial ‘pills’ show promise for detecting gut bleeding in mice

Von KI berichtet Bild generiert von KI Fakten geprüft

Researchers have developed tiny ingestible hydrogel microspheres packed with engineered bacteria that glow when they encounter blood in the gut, potentially offering a quick, noninvasive way to monitor intestinal disease. In mouse models of colitis, the sensors detected heme — a component of blood — within minutes and produced stronger signals as disease severity increased.

A small clinical trial shows that faecal microbiota transplants can improve outcomes for kidney cancer patients on immunotherapy drugs. Participants receiving transplants experienced longer cancer stability and greater tumor shrinkage compared to those given placebos. The approach targets the gut microbiome to boost immune responses against tumors.

Von KI berichtet

A retired US Marine officer in Massachusetts, plagued by a gut that brewed its own alcohol, has seen his symptoms resolve after receiving faecal transplants from a healthy donor. The treatment targeted the rare auto-brewery syndrome, where gut microbes ferment sugars into intoxicating levels of alcohol. This case highlights potential new avenues for managing the condition triggered by antibiotic use.

Cases of colorectal cancer in people under 50 are increasing in many countries, alarming health experts. A recent international study found rising incidence in 27 of 50 countries through 2017, while researchers point to lifestyle factors, obesity and inherited genetic risks, and highlight new non‑invasive tests that could help close screening gaps.

Von KI berichtet

Researchers have identified 50 bacterial species strongly associated with markers of good health in the gut microbiome, based on data from over 34,000 people. The findings highlight links to cholesterol control, reduced inflammation, and better blood sugar management. This work aims to define what constitutes a healthy microbial community amid ongoing debates over its composition.

Soziale Medien summen vor Diskussionen darüber, dass viele Kenianer Schwierigkeiten haben, sich richtig beim Hocken über ländlichen Latrinen zu entleeren. Gastroenterologen betonen, dass Hocken die Darmentleerung erleichtert und Probleme verhindert. Wissenschaftliche Studien stützen diese Behauptungen.

Von KI berichtet

A Cold Spring Harbor Laboratory study demonstrated CAR T-cell therapy can reverse age-related intestinal decline in mice by targeting senescent cells. While promising, experts caution on safety risks, off-target effects, dosing, and costs for human use.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen